Early invasive strategy for acute cardiac ischemia is cost effective.

In patients with unstable angina and non-ST segment myocardial infarction treated with aspirin, heparin, and tirofiban, an early invasive strategy with routine angiography and appropriate revascularization has better clinical outcomes, at a relatively minimal increase in cost.